Boris Minev
Equibles does not estimate personal net worth.
About Boris Minev
Calidi Biotherapeutics, Inc. reported in an 8-K filed August 14, 2025 that Boris Minev was terminated as President, Medical and Scientific Affairs, effective July 29, 2025. The proxy statement of Calidi Biotherapeutics, Inc. reports total compensation of $417,731 for Boris Minev in fiscal 2024, including a base salary of $375,000. Disclosed compensation is on record for 2 fiscal years.
“the Compensation Committee of the Board of Directors of the Company approved the elimination of the position of President, Medical and Scientific Affairs, held by Dr. Boris Minev. As a result, Dr. Minev ceased to serve as an executive officer and as a Section 16 officer of the Company, effective July 29, 2025.”
Affiliation history
-
Calidi Biotherapeutics, Inc. (CLDI)
Proxy statement
Start not stated–2025-07-29
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Calidi Biotherapeutics, Inc. (CLDI) | President, Medical & Scientific Affairs | $375,000 | $417,731 |
| 2023 | Calidi Biotherapeutics, Inc. (CLDI) | President, Medical & Scientific Affairs | $320,192 | $400,096 |